GFAP and Cognitive impairment: More recently it has been proposed that plasma GFAP is elevated in patients exhibiting mild cognitive impairment coupled with amyloidosis, and that GFAP-astrocyte labeling correlates specifically with accumulating Aβ in a transgenic mouse model of amyloidosis (De Bastiani et al., 2023).